Vertex PharmaceuticalsVRTX 
$474.16-1.48%24h
-1.48%24h
Global rank113
Market cap$122.19B
Change 7d-3.23%
YTD Performance17.08%
SP500 benchmarkUnderperform
P/E34.14
P/S12.38
Revenue$9.87B
Earnings$3.62B
Dividend yield-
Main Sector
Healthcare
Market capitalization of Vertex Pharmaceuticals (VRTX)
As of November 2024, Vertex Pharmaceuticals has a market cap of $122.19B. This makes Vertex Pharmaceuticals the world's 113th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Vertex Pharmaceuticals from 1991 to 2024
-
Value:-
Market cap history of Vertex Pharmaceuticals from 1991 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $109.07B | 4.02% |
| 2023 | $104.86B | 40.90% |
| 2022 | $74.42B | 31.50% |
| 2021 | $56.59B | -7.08% |
| 2020 | $60.90B | 7.94% |
| 2019 | $56.42B | 32.13% |
| 2018 | $42.70B | 10.58% |
| 2017 | $38.62B | 103.42% |
| 2016 | $18.98B | -41.45% |
| 2015 | $32.43B | 5.92% |
| 2014 | $30.61B | 59.89% |
| 2013 | $19.15B | 77.33% |
| 2012 | $10.80B | 26.17% |
| 2011 | $8.56B | -5.20% |
| 2010 | $9.03B | -18.25% |
| 2009 | $11.04B | 41.05% |
| 2008 | $7.83B | 30.78% |
| 2007 | $5.99B | -37.92% |
| 2006 | $9.64B | 35.24% |
| 2005 | $7.13B | 161.78% |
| 2004 | $2.72B | 2.13% |
| 2003 | $2.67B | -34.70% |
| 2002 | $4.08B | -35.54% |
| 2001 | $6.34B | -65.61% |
| 2000 | $18.43B | 308.57% |
| 1999 | $4.51B | 17.65% |
| 1998 | $3.83B | -9.85% |
| 1997 | $4.25B | -18.01% |
| 1996 | $5.19B | 51.89% |
| 1995 | $3.41B | 76.67% |
| 1994 | $1.93B | -18.92% |
| 1993 | $2.38B | 89.74% |
| 1992 | $1.26B | -33.90% |
| 1991 | $1.90B | - |
VRTX Market Cap Today is $122.19B -1.48% - 23 Nov 2024
View largest stocks by market cap 
